Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

MVA-5T4 immunotherapy (TroVax) and low-dose cyclophosphamide for advanced colorectal cancer (TaCTiCC): an open-label, randomized phase 1/2 clinical trial

Scurr, Martin, Pembroke, Thomas, Bloom, Anja, roberts, David, Thomson, Amanda, Smart, Kathryn, Bridgeman, Hayley, Admas, Richard, Brewster, Alison, Jones, Robert, Gwynne, Sarah, Blount, Daniel, Harrop, Richard, Wright, Melissa, Hills, Robert, Gallimore, Awen and Godkin, Andrew 2017. MVA-5T4 immunotherapy (TroVax) and low-dose cyclophosphamide for advanced colorectal cancer (TaCTiCC): an open-label, randomized phase 1/2 clinical trial. JAMA Oncology
Item availability restricted.

[img] PDF - Accepted Post-Print Version
Restricted to Repository staff only

Download (2MB)
Item Type: Article
Status: In Press
Schools: Medicine
Subjects: R Medicine > R Medicine (General)
Publisher: American Medical Association (AMA)
ISSN: 2374-2437
Date of First Compliant Deposit: 25 August 2017
Date of Acceptance: 19 June 2017
Last Modified: 12 Apr 2019 15:00
URI: http://orca.cf.ac.uk/id/eprint/102722

Actions (repository staff only)

Edit Item Edit Item

Downloads

Downloads per month over past year

View more statistics